Search clinical trials for: Treadmill locomotor training

Total 11398 results

NYU Langone Health
MOUNT SINAI HOSPITAL

Withdrawn

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Glioma | Glioblastoma

United States
Celgene

Terminated

Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States, Puerto Rico
Amer Zureikat

Completed

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

Pancreatic Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital

Completed

Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Stomach Cancer | Esophageal Cancer

United States
Institut Mutualiste Montsouris

Unknown

Prospective RCT on Post Prostatectomy Urine Leak

Urinary Incontinence | Prostate Cancer

France
Stanford University
Eli Lilly and Company; Genentech, Inc.

Completed

Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer

Lung Cancer | Non-small Cell Lung Cancer (NSCLC)

United States
Memorial Sloan Kettering Cancer Center

Completed

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

Lung Cancer

United States
Aktion Bronchialkarzinom e.V.
Roche Pharma AG

Completed

Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab (INNOVATIONS)

Carcinoma, Non-Small-Cell Lung

Germany
Carolyn Lauckner
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals (TRAC-ER)

HIV Infections | Risk Behavior | Alcohol Use Disorder

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

Pancreatic Cancer

United States
University of Utah
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program (MAINTAIN PRIME)

Diabetes | Weight Loss | Diet Habit

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH); University of California, San Francisco

Recruiting

Suubi+Adherence4Youth

HIV

Uganda
Massachusetts General Hospital
Washington University School of Medicine

Not yet recruiting

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Skin Cancer | Actinic Keratoses | Immunotherapy | Cutaneous Squamous Cell Carcinoma | Organ Transplant Recipients

United States
M.D. Anderson Cancer Center

Completed

Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | B-Lymphoid Malignancies | Non-hodgkin Lymphoma

United States
Hospital de la Soledad

Withdrawn

Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19 (NUTROVID)

Covid19

Mexico
National Cancer Institute, Naples
Unity Health Toronto; University of Catania

Active, not recruiting

Diet, Exercise and Vitamin D in Breast Cancer Recurrence (DEDiCa)

Breast Cancer

Italy
Alexandria University

Completed

Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity

Osteopenia of Prematurity

Egypt
Karuna Therapeutics

Completed

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-1)

Schizophrenia

United States
University Health Network, Toronto
Hoffmann-La Roche

Completed

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Colorectal Cancer

Canada
Northwestern University
National Cancer Institute (NCI)

Completed

Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer

Pancreatic Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Melanoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Bladder Cancer
Rabin Medical Center

Unknown

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Advanced Gastric Cancer

Israel
University of British Columbia

Completed

Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.

Macular Degeneration

Canada
British University In Egypt

Not yet recruiting

Efficacy of Thyme Honey in The Management of Oral Aphthous Ulcers

Treatment Compliance | Aphthous Stomatitis (Major) (Minor)

Egypt
Johns Hopkins All Children's Hospital
Cannonball Kids' Cancer Foundation; Swim Across America Foundation; Benjamin...

Not yet recruiting

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Lymphocytes

United States
Massachusetts General Hospital
Sanofi; GlaxoSmithKline

Not yet recruiting

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma (ISABELA)

Multiple Myeloma | Refractory Multiple Myeloma | Relapsed Cancer

United States
The University of Texas Medical Branch, Galveston
National Institute on Aging (NIA)

Recruiting

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

Urinary Bladder, Overactive | Urinary Incontinence | Accidental Falls

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Non-Small Cell Lung Cancer

China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Refractory and/or Relapsed Metastatic Solid Tumors

United States
University of Miami

Completed

Sleep, Diet, Exercise and Older Persons

Cognitive Change | Cognitive Decline

United States
Sumitomo Pharma Co., Ltd.

Completed

A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Japan
Brigham and Women's Hospital

Completed

Blue Sky Study: Impact of Milk and Vitamin D for Child Growth and Health (BSS)

Vitamin d Deficiency
GlaxoSmithKline

Completed

Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices

Oral Hygiene | Extrinsic Dental Stain

Canada
Amgen

Terminated

A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

Advanced Non-squamous NSCLC
Azienda Ospedaliero, Universitaria Pisana

Completed

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer (MOMA)

Metastatic Colorectal Cancer

Italy
EPS Corporation

Completed

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases (ATOM ES)

Colorectal Cancer | Liver Metastasis

Japan
Washington University School of Medicine

Terminated

Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

Colorectal Cancer | Metastases

United States
Thomas Hatschek

Unknown

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early (PROMIX)

Breast Cancer

Sweden
Maturi, Raj K., M.D., P.C.

Completed

Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema

Diabetic Macular Edema

United States
Heidelberg University

Unknown

Molecular Determinants for Therapy Response on Renal Cell Carcinoma (MORE)

Renal Cell Carcinoma

Germany
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Glioblastoma

United States
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sankyo Pharma Gmbh

Completed

Olmesartan Medoxomil in Hypertension and Renal Impairment

Renal Impairment | Essential Hypertension

Germany
Hellenic Oncology Research Group

Completed

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer

Breast Cancer

Greece
National Institute on Aging (NIA)
Alzheimer's Disease Cooperative Study (ADCS)

Completed

Anti-Oxidant Treatment of Alzheimer's Disease

Alzheimer's Disease

United States
McGill University
Global Affairs Canada; World Vision Canada

Not yet recruiting

Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services (REACTS-IN)

Stunting | Diet; Deficiency | Empowerment | Acceptability of Health Care | Gender Equality

Bangladesh, Kenya, Tanzania
Kangbuk Samsung Hospital

Recruiting

Trastuzumab, Bevacizumab With Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy (TREAZURE)

HER2-positive Advanced Gastric Cancer

Korea, Republic of
Hoffmann-La Roche

Active, not recruiting

A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation (CRISTALLO)

Chronic Lymphocytic Leukemia (CLL)

United States, Italy, Australia, Spain, France
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Breast Cancer

United States, Canada

Search clinical trials for: Treadmill locomotor training

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations